NYSE · Medical - Distribution

PBH (PBH) Stock

$55.06 +1.16% NYSE: PBH Healthcare

Valuation

MetricValue
Price$55.06
Market Cap$2.61B
P/E Ratio11.92
P/B Ratio1.17
P/S Ratio2.03
EPS (TTM)$3.91
52-Week High$85.29
52-Week Low$42.62
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.06%
ROA5.36%
ROCE16.37%
Gross Margin28.47%
Operating Margin28.37%
Net Margin17.48%
Debt/Equity0.55
Current Ratio3.56

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.1B$1.1B$1.1B$1.1B$1.1B
Operating Profit$330.0M$-22.0M$342.0M$337.0M$309.0M
Net Profit$205.0M$-82.0M$209.0M$215.0M$190.0M
EPS$4.04$-1.65$4.17$4.29$3.91
Op Margin30.4%-2.0%30.4%29.6%28.4%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$3.7B$3.4B$3.3B$3.4B$3.5B
Total Liabilities$2.1B$1.9B$1.7B$1.6B$1.7B
Cash$27.0M$58.0M$46.0M$98.0M$64.0M
Borrowings$1.5B$1.4B$1.1B$1.0B$1.0B

Latest News

Is the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock? Zacks · Jul 6, 2026 Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date GlobeNewswire · Jul 6, 2026 Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition Insider Monkey · Jul 4, 2026 Alphabet Joined the Dow and Became a Top Holding in Berkshire Hathaway's Portfolio. But This Stock Could Be an Even Better Buy. Motley Fool · Jul 3, 2026 Prestige Plans $400 Million Private Offering of Senior Notes MT Newswires · Jun 30, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$260.0M$230.0M$249.0M$252.0M$265.0M
Investing Cash Flow$-266.0M$-19.0M$-30.0M$-26.0M$-148.0M
Financing Cash Flow$-2.0M$-48.0M$-13.0M$-57.0M$-161.0M
Net Cash Flow$-5.0M$31.0M$-12.0M$51.0M$-34.0M
Free Cash Flow$250.0M$222.0M$239.0M$243.0M$254.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA9.38
FCF Yield11.52%
Quick Ratio2.25
Interest Coverage7.36
Return 1Y-35.85%
Return 3Y-21.19%
Return 5Y-6.77%

Ownership

Insiders Held1.38%
Institutions Held113.97%
Institutions Float Held115.56%
Institutional HolderSharesReport Date
Blackrock Inc.7,388,4902026-03-31
Ariel Investments, LLC4,274,3262026-03-31
Vanguard Portfolio Management LLC2,803,8282026-03-31
Dimensional Fund Advisors LP2,672,7772026-03-31
Kayne Anderson Rudnick Investment Management LLC2,202,6062026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATEC $9.65 +3.54% -8.57 $1.48B 0.00%
CON $30.76 -1.16% 19.32 $3.94B 0.99%
CPRX $31.49 +0.00% 18.00 $3.85B 0.00%
HTFL $28.82 +5.99% -101.97 $2.49B 0.00%
ICUI $166.53 +0.46% 4102.67 $4.16B 0.00%

About PBH

PBH stock trades at $55.06 with a market capitalization of $2.61B. The stock is valued at a price-to-earnings (P/E) ratio of 11.92, price-to-book of 1.17, price-to-sales of 2.03. Over the past 52 weeks the stock has ranged between $42.62 and $85.29, and currently trades 35.4% below its 52-week high.

On profitability, PBH generates a return on equity (ROE) of 10.06%, return on capital employed of 16.37%, an operating margin of 28.37%, a net profit margin of 17.48%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides